Renin-Angiotensin-Aldosterone Axis Inhibition Improves Outcome of Diabetic Patients with Chronic Hypertension and COVID-19: An Iranian Perspective

BACKGROUND: Safe use of drugs such as angiotensin-converting enzyme 2 (ACE2) inhibitors and angiotensin receptor blockers (ARBs) in COVID diabetic patients needs comprehensive studies. This study addressed this issue from the Iranian perspective. MATERIALS AND METHODS: Admitted COVID-19 patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheyri, Zahedin, Alizadeh, Mahboobeh, Akbarpour, Samaneh, Hosamirudsari, Hadiseh, Niya, Mohammad H. K., Aliasgharpour, Fatemeh, Meidan, Mohadeseh M., Hassanzadeh, Shahrbanoo, Dowran, Razieh, Jafarpour, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926032/
https://www.ncbi.nlm.nih.gov/pubmed/36798924
http://dx.doi.org/10.4103/abr.abr_177_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926032/
https://www.ncbi.nlm.nih.gov/pubmed/36798924
http://dx.doi.org/10.4103/abr.abr_177_21

Ejemplares similares